Bexen Medical

Founded in 1978 in Gipuzkoa, Spain, Bexen Medical focuses on developing and supplying medical equipment and services. The company has evolved its strategies to serve a wide range of healthcare providers across the globe. In November 2023, Cocoon Bioscience SL raised EUR 2 million in venture funding co-led by investors Mondragon Corporation and Bexen Medical, with participation from other investors Gestión de Capital Riesgo del País Vasco and Sangha Capital. Returning investors Cleon Capital, Viscofan, Columbus Venture Partners, Viscofan, North South Ventures, and other investors also participated in the round.

  Bexen Medical and Bioservices provides a variety of medical products facilitating healthcare delivery. Their offerings include biological samples, ultra-low temperature storage solutions through Stirling Ultracold equipment, and advanced defibrillation devices from Bexen Cardio. These products are intended for hospitals, research institutions, and clinics in markets including Europe, Africa, Asia, and South America, adhering to rigorous health standards. Bexen Medical is poised to launch new products in the upcoming year aimed at expanding its portfolio in the healthcare sector.

Additionally, they have plans to penetrate new markets in Asia and Africa by 2024, leveraging recent funding to scale operations and enhance product development initiatives.